Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease

• Published in: Frontiers in endocrinology (Lausanne) Vol. 11; p. 590
• Main Authors: Zhao, Yanyan, Shen, Ao, Guo, Feng, Song, Yi, Jing, Na, Ding, Xiaoxu, Pan, Mengxing, Zhang, Haohao, Wang, Jiao, Wu, Lina, Ma, Xiaojun, Feng, Liang, Qin, Guijun
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 28-08-2020
• Subjects: Aged; biomarker; Biomarkers - urine; diabetic kidney disease; Diabetic Nephropathies - diagnosis; Diabetic Nephropathies - urine; diagnostic value; Endocrinology; Exosomes - metabolism; Gene Expression Profiling; Humans; Kidney - metabolism; Male; MicroRNAs - urine; Middle Aged; MiRNA; urinary exosomes; diabetic kidney disease; urinary exosomes; biomarker; diagnostic value; MiRNA
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2020.00590

Urinary exosomal miRNAs can reflect the physiological and possibly pathophysiological state of cells lining the kidney and participate in the regulation of transcription and translation of proteins, which are playing an important role in the pathogenesis of diabetic kidney disease. In the present study, urine was collected from DM and DKD patients with a duration more than 10 years and urinary exosomal miRNA profiling was conducted in urinary exosomes obtained from three patients with type 2 diabetes (DM) and three patients with type 2 diabetic kidney disease (DKD) using Exiqon's microRNA arrays. In total, the expression of 14 miRNAs (miR-4491, miR-2117, miR-4507, miR-5088-5P, miR-1587, miR-219a-3p, miR-5091, miR-498, miR-4687-3p, miR-516b-5p, miR-4534, miR-1275, miR-5007-3p, and miR-4516) was up-regulated (>2-fold) in DKD patients compared to healthy controls and DM patients. We used qRT-PCR based analysis of these 14 miRNAs in urinary exosomes from 14 DKD to 14 DM patients in confirmation cohort, among which seven miRNAs were consistent with the microarray results. The expressions of miR-4534 and miR-516b-5p correlated with trace proteinuria levels in the confirmation cohort. In conclusion, it has been confirmed that the expression of urinary exosomal miRNA in patients with type 2 diabetes DKD has changed. Mir-4534 might affect the FoxO signaling pathway by targeting BNIP3, and is expected to become a new biomarker for the progression of type 2 DKD disease, which will provide further research on the pathogenesis of DKD.